nach oben

Erschienen in:

01.01.2014 | Original Article

Impact of symptom burden in post-surgical non-small cell lung cancer survivors

verfasst von: Amy E. Lowery, Paul Krebs, Elliot J. Coups, Marc B. Feinstein, Jack E. Burkhalter, Bernard J. Park, Jamie S. Ostroff

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pain, fatigue, dyspnea, and distress are commonly reported cancer-related symptoms, but few studies have examined the effects of multiple concurrent symptoms in longer-term cancer survivors. We examined the impact of varying degrees of symptom burden on health-related quality of life (HRQOL) and performance status in surgically treated non-small cell lung cancer (NSCLC) survivors.

Methods

A sample of 183 NSCLC survivors 1–6 years post-surgical treatment completed questionnaires assessing five specific symptoms (pain, fatigue, dyspnea, depression, and anxiety), HRQOL, and performance status. The number of concurrent clinically significant symptoms was calculated as an indicator of symptom burden.

Results

Most survivors (79.8 %) had some degree of symptom burden, with 30.6 % reporting one clinically significant symptom, 27.9 % reporting two symptoms, and 21.3 % reporting three or more symptoms. Physical HRQOL significantly decreased as the degree of symptom burden increased, but mental HRQOL was only significantly decreased in those with three or more symptoms. Receiver-operating characteristic (ROC) curves showed that having multiple concurrent symptoms (two or more) was most likely associated with limitations in functioning (area under a ROC curve = 0.75, sensitivity = 0.81, specificity = 0.54).

Conclusions

Two or more clinically significant symptoms are identified as the “tipping point” for showing adverse effects on HRQOL and functioning. This highlights the need for incorporating multiple-symptom assessment into routine clinical practice. Comprehensive symptom management remains an important target of intervention for improved post-treatment HRQOL and functioning among lung cancer survivors.

American Cancer Society (2012) Cancer facts & figures 2012. American Cancer Society, Atlanta

Hewitt M, Rowland JH, Yancik R (2003) Cancer survivors in the United States: age, health, and disability. J Gerontol A: Biol Med Sci 58:82–91CrossRef

National Institute of Health (2002) NIH State-of-the-Science Statement on symptom management in cancer: pain, depression, and fatigue. NIH Consens State Sci Statements 19(4):1–29

Shi Q, Smith TG, Michonski JD, Stein KD, Kaw C, Cleeland CS (2011) Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer 117:2779–2790PubMedCrossRef

Burkett VS, Cleeland CS (2007) Symptom burden in cancer survivorship. J Cancer Survivorship Res Pract 1:167–175CrossRef

Cheville AL, Novotny PJ, Sloan JA et al (2011) Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer. J Pain Symptom Manag 42:202–212CrossRef

Eversley R, Estrin D, Dibble S, Wardlaw L, Pedrosa M, Favila-Penney W (2005) Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum 32:250–256PubMedCrossRef

Fu OS, Crew KD, Jacobson JS et al (2009) Ethnicity and persistent symptom burden in breast cancer survivors. J Cancer Survivorship Res Pract 3:241–250CrossRef

Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M (2010) It's not over when it's over: long-term symptoms in cancer survivors–a systematic review. Int J Psychiatry Med 40:163–181PubMedCrossRef

10.

Sarna L, Padilla G, Holmes C, Tashkin D, Brecht ML, Evangelista L (2002) Quality of life of long-term survivors of non-small-cell lung cancer. J Clin Oncol Off J Am Soc Clin Oncol 20:2920–2929CrossRef

11.

Svobodnik A, Yang P, Novotny PJ et al (2004) Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis. Mayo Clin Proc Mayo Clin 79:1024–1030CrossRef

12.

Cheville AL, Novotny PJ, Sloan JA et al (2011) The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors. J Pain Symptom Manag 42:213–221CrossRef

13.

Cleeland CS (2007) Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr 37:16–21PubMedCrossRef

14.

Cooley ME, Short TH, Moriarty HJ (2002) Patterns of symptom distress in adults receiving treatment for lung cancer. J Palliat Care 18:150–159PubMed

15.

Dodd MJ, Cho MH, Cooper BA, Miaskowski C (2010) The effect of symptom clusters on functional status and quality of life in women with breast cancer. Eur J Oncol Nurs Off J Eur Oncol Nurs Soc 14:101–110CrossRef

16.

Dodd MJ, Miaskowski C, Paul SM (2001) Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum 28:465–470PubMed

17.

Esther Kim JE, Dodd MJ, Aouizerat BE, Jahan T, Miaskowski C (2009) A review of the prevalence and impact of multiple symptoms in oncology patients. J Pain Symptom Manag 37:715–736CrossRef

18.

Ferreira KA, Kimura M, Teixeira MJ et al (2008) Impact of cancer-related symptom synergisms on health-related quality of life and performance status. J Pain Symptom Manag 35:604–616CrossRef

19.

Gift AG, Stommel M, Jablonski A, Given W (2003) A cluster of symptoms over time in patients with lung cancer. Nurs Res 52:393–400PubMedCrossRef

20.

Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D (2008) Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 16:791–801

21.

Jones JM, Cohen SR, Zimmermann C, Rodin G (2010) Quality of life and symptom burden in cancer patients admitted to an acute palliative care unit. J Palliat Care 26:94–102PubMed

22.

Kirkova J, Aktas A, Walsh D, Davis MP (2011) Cancer symptom clusters: clinical and research methodology. J Palliat Med 14:1149–1166PubMedCrossRef

23.

Miaskowski C, Cooper BA, Paul SM et al (2006) Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum 33:E79–E89PubMedCrossRef

24.

Molassiotis A, Wengstrom Y, Kearney N (2010) Symptom cluster patterns during the first year after diagnosis with cancer. J Pain Symptom Manag 39:847–858CrossRef

25.

Rausch SM, Clark MM, Patten C et al (2010) Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors. Cancer 116:4103–4113PubMedCrossRef

26.

Wang XS, Shi Q, Williams LA et al (2010) Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun 24:968–974PubMedCrossRef

27.

Buchanan D, Milroy R, Baker L, Thompson AM, Levack PA (2009) Perceptions of anxiety in lung cancer patients and their support network. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 18:29–36

28.

Institute of Medicine (2005) From cancer patient to cancer survivor: lost in transition. The National Academies, Washington DC

29.

Portenoy RK, Thaler HT, Kornblith AB et al (1994) Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res Int J Qual Life Asp Treat Care Rehab 3:183–189CrossRef

30.

Sun V, Ferrell B, Juarez G, Wagman LD, Yen Y, Chung V (2008) Symptom concerns and quality of life in hepatobiliary cancers. Oncol Nurs Forum 35:E45–E52PubMedCrossRef

31.

Cleeland CS, Ryan KM (1994) Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med 23:129–138

32.

Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61:277–284PubMedCrossRef

33.

Temel JS, Pirl WF, Lynch TJ (2006) Comprehensive symptom management in patients with advanced-stage non-small-cell lung cancer. Clin Lung Cancer 7:241–249PubMedCrossRef

34.

Hung R, Krebs P, Coups EJ et al (2011) Fatigue and functional impairment in early-stage non-small cell lung cancer survivors. J Pain Symptom Manag 41:426–435CrossRef

35.

Feinstein MB, Krebs P, Coups EJ et al (2010) Current dyspnea among long-term survivors of early-stage non-small cell lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 5:1221–1226

36.

Ostroff JS, Krebs P, Coups EJ et al (2011) Health-related quality of life among early-stage, non-small cell, lung cancer survivors. Lung Cancer 71:103–108PubMedCrossRef

37.

Krebs P, Coups EJ, Feinstein MB et al (2012) Health behaviors of early-stage non-small cell lung cancer survivors. J Cancer Survivorship Res Pract 6:37–44CrossRef

38.

Buist AS, Connett JE, Miller RD, Kanner RE, Owens GR, Voelker HT (1993) Chronic obstructive pulmonary disease early intervention trial (lung health study). Baseline characteristics of randomized participants. Chest 103:1863–1872PubMedCrossRef

39.

Ware JJ, Kosinski M, Gandek B (2000) SF-36 health survey: manual and interpretation guide. QualityMetric, Inc., Lincoln

40.

Mendoza TR, Wang XS, Cleeland CS et al (1999) The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85:1186–1196PubMedCrossRef

41.

Mahler DA, Weinberg DH, Wells CK, Feinstein AR (1984) The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 85:751–758PubMedCrossRef

42.

Eakin EG, Sassi-Dambron DE, Ries AL, Kaplan RM (1995) Reliability and validity of dyspnea measures in patients with obstructive lung disease. Int J Behav Med 2:118–134PubMedCrossRef

43.

Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370PubMedCrossRef

44.

Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561–577PubMed

45.

Cella D, Nichol MB, Eton D, Nelson JB, Mulani P (2009) Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy–Prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer. Value Health J Int Soc Pharmacoecon Outcomes Res 12:124–129CrossRef

Titel: Impact of symptom burden in post-surgical non-small cell lung cancer survivors
verfasst von: Amy E. Lowery
Paul Krebs
Elliot J. Coups
Marc B. Feinstein
Jack E. Burkhalter
Bernard J. Park
Jamie S. Ostroff
Publikationsdatum: 01.01.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 1/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-013-1968-3

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Impact of symptom burden in post-surgical non-small cell lung cancer survivors